Heekyoung Yang
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5.
Journal: Neoplasia (New York, N.Y.)
Published: November 16, 2022
Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics.
Journal: Membranes
Published: December 07, 2021
Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target.
Journal: Experimental & molecular medicine
Published: November 05, 2020
Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts.
Journal: Cancers
Published: October 08, 2020
Synthesis and biological evaluation of potent benzoselenophene and heteroaromatic analogues of (S)-1-(chloromethyl)-8-methoxy-2,3-dihydro-1H-benzo[e]indol-5-ol (seco-MCBI).
Journal: RSC advances
Published: June 24, 2019
Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target.
Journal: Experimental & molecular medicine
Published: March 02, 2019
Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations.
Journal: Scientific reports
Published: August 07, 2018
Synthesis and anticancer activity of benzoselenophene and heteroaromatic derivatives of 1,2,9,9a-tetrahydrocyclopropa[c]benzo[e]indol-4-one (CBI).
Journal: Organic & biomolecular chemistry
Published: January 17, 2017
Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy.
Journal: Oncotarget
Published: December 03, 2015
Facilitating tailored therapeutic strategies for glioblastoma through an orthotopic patient-derived xenograft platform.
Journal: Histology and histopathology
Published: November 19, 2015
Last Updated: 09/26/2026